Marek Brzosko
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda(IT)Società Italiana di Reumatologia(IT)Pomeranian Medical University(PL)
Publications by Year
Research Areas
Systemic Lupus Erythematosus Research, Systemic Sclerosis and Related Diseases, Vasculitis and related conditions, Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments
Most-Cited Works
- → Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structu(2010)413 cited
- → Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study(2016)227 cited
- → The expansion of CD4+CD28- T cells in patients with rheumatoid arthritis(2003)123 cited
- → Tocilizumab Inhibits Structural Joint Damage and Improves Physical Function in Patients with Rheumatoid Arthritis and Inadequate Responses to Methotrexate: LITHE Study 2-year Results(2013)122 cited
- → Efficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib(2005)73 cited
- →